An in-depth look to INTRON BIOTECHNOLOGY, INC. operating, investing, and financing activities

048530 free cash flow for Q3 24 is -791.84 M KRW. For 2023, 048530 free cash flow was -5.76 B KRW and operating cash flow was 3.47 B KRW.